Coagulation activation in patients with an inflammatory syndrome: Is there a link with acquired protein S deficiency?

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 2, 1998, Pages 167-171

  Boullanger, N ^a   El Kouri, D ^a   Trossaert M ^a   Truchaud, F ^a   Trewick, D ^a   Planchon, B ^a  

^a HÔTEL DIEU   (France)

Author keywords

C4 binding protein; Coagulation; Inflammation; Plasminogen activator inhibitor; Protein S

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN S DEFICIENCY;

EID: 0031967336     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199803000-00007     Document Type: Article

References (15)

1. Talbot RW, Hepell J, Dozois RR, Ecart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145.
2. Naschitz JE, Yeshurun D, Lev LM. Thromboembolism in cancer. Changing trends. Cancer 1993; 71: 1384-1390.
3. Hesselvik JF, Malm J, Dahlbäck B, Blombäck M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65: 126-129.
4. Dosquet C, Weill D, Wautier JL. Cytokines and thrombosis. J Cardiovasc Pharmacol 1995; 25: S13S19.
5. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activating complex by protein S. Evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 1062-1071.
6. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. / Clin Invest 1984; 74: 2082-2088.
7. D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. / Clin Invest 1988; 81: 1445-1454.
8. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69: 692-694.
9. d'Angelo A, Gerosa S, Vigano d'Aneglo S. Protein S and protein C anticoagulant activity in acute and chronic cardiac ischémie syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity. Thromb Research 1994; 75:133-142.
10. de Frutos PG, Alim RIM, Härdig Y, Zöller B, Dahlbäck B. Differential regulation of a and ßchains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-822.
11. Bauer KA, ten Gate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on hemostatic mechanism of humans. Blood 1989; 74: 165-172.
12. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebutt S, Williamson RCN. Extrinsic-pathway activation in cancer with high factor Vila and tissue factor. Lancet 1995; 346: 1004-1005.
13. Barnum SR, Dahlbäck B. C4-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase reactant and is elevated in systemic lupus erythemamatosus. Complement Inflamm 1990; 7: 71-77.
14. Griffin JH, Gruber A, Fernândez JA. Réévaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood 1992; 79: 3203-3211.
15. Garcia OC, Sanchez-Corral P, Rodriguez de Cordoba S. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. / Immunol 1995; 155: 40374043.